| Oct 3 |
Eton Pharmaceuticals, Inc to Acquire Increlex® (mecasermin injection) from Ipsen
|
| Sep 13 |
Opaleye Management Inc. Increases Stake in Eton Pharmaceuticals Inc.
|
| Aug 22 |
Eton Pharmaceuticals to Participate at the H.C. Wainwright 26th Annual Global Investment Conference
|
| Aug 11 |
Eton Pharmaceuticals Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
| Aug 11 |
Eton Pharmaceuticals, Inc. (ETON) Q2 2024 Earnings Call Transcript
|
| Aug 8 |
Eton Pharmaceuticals GAAP EPS of -$0.12 misses by $0.05, revenue of $9.07M beats by $0.27M
|
| Aug 8 |
Eton Pharmaceuticals Reports Second Quarter 2024 Financial Results
|
| Aug 7 |
Eton Pharmaceuticals Q2 2024 Earnings Preview
|
| Aug 2 |
Shareholders in Eton Pharmaceuticals (NASDAQ:ETON) are in the red if they invested five years ago
|
| Jul 30 |
Eton Pharmaceuticals to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024
|
